CLINICAL_TRIALS
trial_result
· 2016-03-09
Clinical Trial Update: BAY1238097, First in Man [Phase 1]
Summary
Bayer's BAY1238097, a first-in-man Phase 1 trial for neoplasms, has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Neoplasms | Phase 1 | Status: TERMINATED